UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

Annals of oncology, 2019-04, Vol.30 (4), p.582-588

2019

Link zum Volltext

Verfügbarkeit prüfen

Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma

Clinical radiology, 2011-03, Vol.66 (3), p.224-236

2011

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma

Cancer chemotherapy and pharmacology, 2011-03, Vol.67 (3), p.657-666

2011

Link zum Volltext

Verfügbarkeit prüfen

Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma

Cancer, 1999-12, Vol.86 (11), p.2252-2258

1999

Link zum Volltext

Verfügbarkeit prüfen

Renal cell carcinoma: A paradigm of lanthanic disease

American journal of clinical oncology, 1999-06, Vol.22 (3), p.223-231

1999

Link zum Volltext

Verfügbarkeit prüfen

Temozolomide plus thalidomide in patients with brain metastases from melanoma : A phase II study

Cancer, 2005-06, Vol.103 (12), p.2590-2597

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma

Journal of clinical oncology, 2003-09, Vol.21 (17), p.3351-3356

2003

Link zum Volltext

Verfügbarkeit prüfen

Clinical results using biochemotherapy as a standard of care in advanced melanoma

Melanoma research, 2002-08, Vol.12 (4), p.381-387

2002

Link zum Volltext

Verfügbarkeit prüfen

Treatment of malignant pleural effusions with tunneled long-term drainage catheters

Journal of vascular and interventional radiology, 2001-02, Vol.12 (2), p.201

2001

Link zum Volltext

Verfügbarkeit prüfen

Treatment of metastatic melanoma in the brain with temozolomide and thalidomide

The lancet oncology, 2001-10, Vol.2 (10), p.634-635

2001

Link zum Volltext

Verfügbarkeit prüfen

New approaches in the treatment of metastatic melanoma: thalidomide and temozolomide

Oncology (Williston Park, N.Y.), 2000-12, Vol.14 (12 Suppl 13), p.25

Hwu, W J

2000

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside

Vaccine, 2004-07, Vol.22 (21), p.2904-2909

2004

Link zum Volltext

Verfügbarkeit prüfen

Temozolomide Plus Thalidomide in Patients With Advanced Melanoma: Results of a Dose-Finding Trial

Journal of clinical oncology, 2002-06, Vol.20 (11), p.2610-2615

2002

Link zum Volltext

Verfügbarkeit prüfen

Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases

Melanoma research, 2012-08, Vol.22 (4), p.310-315

2012

Link zum Volltext

Verfügbarkeit prüfen

Systemic chemotherapy

Clinics in plastic surgery, 2000-07, Vol.27 (3), p.451

2000

Link zum Volltext

Verfügbarkeit prüfen

A clinical-pharmacological evaluation of percutaneous isolated hepatic infusion of doxorubicin in patients with unresectable liver tumors

Oncology research, 1999, Vol.11 (11-12), p.529

1999

Link zum Volltext

Verfügbarkeit prüfen

The safety of temozolomide in the treatment of malignancies

Expert opinion on drug safety, 2009-07, Vol.8 (4), p.493-499

2009

Link zum Volltext

Verfügbarkeit prüfen

Staging work-up and post-treatment surveillance of patients with melanoma

Clinics in plastic surgery, 2000-07, Vol.27 (3), p.377

2000

Link zum Volltext

Verfügbarkeit prüfen

Consistent Antibody Response against Ganglioside GD2 Induced in Patients with Melanoma by a GD2 Lactone-Keyhole Limpet Hemocyanin Conjugate Vaccine plus Immunological Adjuvant QS-21

Clinical cancer research, 2003-11, Vol.9 (14), p.5214-5220

2003

Link zum Volltext

Verfügbarkeit prüfen

Sequential Immunization of Melanoma Patients with GD3 Ganglioside Vaccine and Anti-Idiotypic Monoclonal Antibody That Mimics GD3 Ganglioside

Clinical cancer research, 2004-07, Vol.10 (14), p.4717-4723

2004

Link zum Volltext

Verfügbarkeit prüfen

T-Cell responses against tyrosinase 368-376(370D) peptide in HLAA0201+ melanoma patients: Randomized trial comparing incomplete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, and QS-21 as immunological adjuvants

Clinical cancer research, 2002-05, Vol.8 (5), p.967-972

2002

Link zum Volltext

Verfügbarkeit prüfen

Response of stage IV anal mucosal melanoma to chemotherapy

The lancet oncology, 2005-06, Vol.6 (6), p.438-439

2005

Link zum Volltext

Verfügbarkeit prüfen

Colonic Melanoma, Primary or Regressed Primary

Journal of clinical gastroenterology, 2000-06, Vol.30 (4), p.441-444

2000

Link zum Volltext

Verfügbarkeit prüfen

Primary malignant melanoma of the oesophagus: a clinical and pathological study with emphasis on the immunophenotype of the tumours for melanocyte differentiation markers and cancer/testis antigens

Melanoma research, 2003-12, Vol.13 (6), p.595-601

2003

Link zum Volltext

Verfügbarkeit prüfen

Hypertrophic osteoarthropathy associated with metastatic melanoma

Melanoma research, 2005-12, Vol.15 (6), p.559-561

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 70

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieInvestigational New Drugs

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(70)

Sprache

Englisch
(70)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(66)
Science & Technology
(57)
Life Sciences & Biomedicine
(54)
Male
(45)
Female
(44)
Biological And Medical Sciences
(35)
Adult
(33)
Medical Sciences
(32)
Middle Aged
(31)
Schizophrenia
(22)
Oncology
(21)
Aged
(17)
Psychiatry
(17)
Schizophrenia - Genetics
(17)
Melanoma - Pathology
(14)
Psychology. Psychoanalysis. Psychiatry
(13)
Melanoma - Drug Therapy
(12)
Psychopathology. Psychiatry
(12)
Adolescent
(11)
Adult And Adolescent Clinical Studies
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma

Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma

Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma

Renal cell carcinoma: A paradigm of lanthanic disease

Temozolomide plus thalidomide in patients with brain metastases from melanoma : A phase II study

Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma

Clinical results using biochemotherapy as a standard of care in advanced melanoma

Treatment of malignant pleural effusions with tunneled long-term drainage catheters

Treatment of metastatic melanoma in the brain with temozolomide and thalidomide

New approaches in the treatment of metastatic melanoma: thalidomide and temozolomide

A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside

Temozolomide Plus Thalidomide in Patients With Advanced Melanoma: Results of a Dose-Finding Trial

Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases

Systemic chemotherapy

A clinical-pharmacological evaluation of percutaneous isolated hepatic infusion of doxorubicin in patients with unresectable liver tumors

The safety of temozolomide in the treatment of malignancies

Staging work-up and post-treatment surveillance of patients with melanoma

Consistent Antibody Response against Ganglioside GD2 Induced in Patients with Melanoma by a GD2 Lactone-Keyhole Limpet Hemocyanin Conjugate Vaccine plus Immunological Adjuvant QS-21

Sequential Immunization of Melanoma Patients with GD3 Ganglioside Vaccine and Anti-Idiotypic Monoclonal Antibody That Mimics GD3 Ganglioside

T-Cell responses against tyrosinase 368-376(370D) peptide in HLAA0201+ melanoma patients: Randomized trial comparing incomplete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, and QS-21 as immunological adjuvants

Response of stage IV anal mucosal melanoma to chemotherapy

Colonic Melanoma, Primary or Regressed Primary

Primary malignant melanoma of the oesophagus: a clinical and pathological study with emphasis on the immunophenotype of the tumours for melanocyte differentiation markers and cancer/testis antigens

Hypertrophic osteoarthropathy associated with metastatic melanoma

Aktive Filter

Suchergebnisse filtern